QuidelOrtho Corporation

25.16
-0.11 (-0.44%)
At close: Apr 17, 2025, 3:59 PM
-0.44%
Bid 24.3
Market Cap 1.7B
Revenue (ttm) 2.78B
Net Income (ttm) -2.03B
EPS (ttm) -30.54
PE Ratio (ttm) -0.82
Forward PE 8.09
Analyst Buy
Ask 28
Volume 755,260
Avg. Volume (20D) 1,025,452
Open 24.83
Previous Close 25.27
Day's Range 24.44 - 25.45
52-Week Range 24.44 - 49.45
Beta 0.43

About QDEL

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical managem...

Sector Healthcare
IPO Date Feb 1, 1991
Employees 6,600
Stock Exchange NASDAQ
Ticker Symbol QDEL
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for QDEL stock is "Buy." The 12-month stock price forecast is $50, which is an increase of 98.73% from the latest price.

Stock Forecasts

Next Earnings Release

QuidelOrtho Corporation is scheduled to release its earnings on May 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+4.28%
QuidelOrtho shares are trading higher after the co... Unlock content with Pro Subscription
4 months ago
+7.84%
QuidelOrtho shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $44 to $50.